Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1996 Mar;117(5):873–878. doi: 10.1111/j.1476-5381.1996.tb15274.x

The effects of purine compounds on the isolated aorta of the frog Rana temporaria.

G E Knight 1, G Burnstock 1
PMCID: PMC1909419  PMID: 8851504

Abstract

1. In the isolated aorta of the frog, Rana temporaria, adenosine concentration-dependently, endothelium-independently relaxed adrenaline pre-constricted vessels. None of the adenosine analogues including D-5'-(N-ethylcarboxamide) adenosine (NECA), R- and S-N6-(2-phenylisopropyl) adenosine (R-and S-PIA) and 2-chloroadenosine (2-CA), or the more selective A1, A2 and A3 agonists cyclopentyladenosine (CPA), CGS 21680 and N6-(3-iodobenzyl) adenosine-5'-N-methylcarboxamide (IB-MECA) respectively, had any effect. 2. The non-selective adenosine antagonist, 8-p-sulphophenyl-theophylline (8-pSPT; 30 microM) failed to inhibit adenosine relaxations, as did NG-nitro-L-arginine methyl ester (L-NAME; 0.1 mM) and indomethacin (30 microM). 3. Adenosine 5'-triphosphate (ATP), alpha, beta-methylene ATP (alpha, beta-MeATP), beta, gamma-methylene ATP (beta, gamma-MeATP), 2-methylthio ATP (2-MeSATP) and uridine 5'-triphosphate (UTP) all concentration-dependently contracted the frog aorta. ATP and alpha, beta-MeATP were equipotent and more potent than UTP and beta, gamma-MeATP; 2-MeSATP had little activity. 4. The P2-purinoceptor antagonist, suramin (0.1 mM) inhibited contractions to alpha, beta-MeATP but not to ATP. Pyridoxalphosphate-6-azophenyl-2',4'-disulphonic acid (PPADS; 30 microM) also inhibited contractions to alpha, beta-MeATP but not to ATP. Contractions to ATP were, however, inhibited by indomethacin (30 microM). 5. In conclusion, in the frog aorta there appears to be a novel subclass of P1-purinoceptor mediating vasodilatation, although like the A3 subclass it is not blocked by methylxanthines; a P2-purinoceptor mediates vasconstriction which resembles a P2x subtype, based on the agonist potency of alpha, beta-MeATP being more potent than 2-MeSATP (UTP has moderate activity) and PPADS is an effective antagonist. There is no evidence for the presence of a P2y-purinoceptor, mediating vasodilatation, in this preparation.

Full text

PDF
873

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abbracchio M. P., Burnstock G. Purinoceptors: are there families of P2X and P2Y purinoceptors? Pharmacol Ther. 1994;64(3):445–475. doi: 10.1016/0163-7258(94)00048-4. [DOI] [PubMed] [Google Scholar]
  2. Alexander S. P., Losinski A., Kendall D. A., Hill S. J. A comparison of A2 adenosine receptor-induced cyclic AMP generation in cerebral cortex and relaxation of pre-contracted aorta. Br J Pharmacol. 1994 Jan;111(1):185–190. doi: 10.1111/j.1476-5381.1994.tb14042.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Berne R. M., Knabb R. M., Ely S. W., Rubio R. Adenosine in the local regulation of blood flow: a brief overview. Fed Proc. 1983 Dec;42(15):3136–3142. [PubMed] [Google Scholar]
  4. Bramich N. J., Edwards F. R., Hirst G. D. Sympathetic nerve stimulation and applied transmitters on the sinus venosus of the toad. J Physiol. 1990 Oct;429:349–375. doi: 10.1113/jphysiol.1990.sp018261. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Brizzolara A. L., Burnstock G. Endothelium-dependent and endothelium-independent vasodilatation of the hepatic artery of the rabbit. Br J Pharmacol. 1991 May;103(1):1206–1212. doi: 10.1111/j.1476-5381.1991.tb12325.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Burnstock G. Evolution of the autonomic innervation of visceral and cardiovascular systems in vertebrates. Pharmacol Rev. 1969 Dec;21(4):247–324. [PubMed] [Google Scholar]
  7. Burnstock G., Kennedy C. Is there a basis for distinguishing two types of P2-purinoceptor? Gen Pharmacol. 1985;16(5):433–440. doi: 10.1016/0306-3623(85)90001-1. [DOI] [PubMed] [Google Scholar]
  8. Burnstock G. Local control of blood pressure by purines. Blood Vessels. 1987;24(3):156–160. doi: 10.1159/000158691. [DOI] [PubMed] [Google Scholar]
  9. Burnstock G., Meghji P. Distribution of P1- and P2-purinoceptors in the guinea-pig and frog heart. Br J Pharmacol. 1981 Aug;73(4):879–885. doi: 10.1111/j.1476-5381.1981.tb08741.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Burnstock G. Vascular control by purines with emphasis on the coronary system. Eur Heart J. 1989 Nov;10 (Suppl F):15–21. doi: 10.1093/eurheartj/10.suppl_f.15. [DOI] [PubMed] [Google Scholar]
  11. Ciabattoni G., Wennmalm A. Adenosine-induced coronary release of prostacyclin at normal and low pH in isolated heart of rabbit. Br J Pharmacol. 1985 Jun;85(2):557–563. doi: 10.1111/j.1476-5381.1985.tb08893.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Colin D. A., Leray C. Interaction of adenosine and its phosphorylated derivatives with putative purinergic receptors in the gill vascular bed of rainbow trout. Pflugers Arch. 1979 Dec;383(1):35–40. doi: 10.1007/BF00584472. [DOI] [PubMed] [Google Scholar]
  13. Collis M. G., Brown C. M. Adenosine relaxes the aorta by interacting with an A2 receptor and an intracellular site. Eur J Pharmacol. 1983 Dec 9;96(1-2):61–69. doi: 10.1016/0014-2999(83)90529-0. [DOI] [PubMed] [Google Scholar]
  14. Collis M. G. The vasodilator role of adenosine. Pharmacol Ther. 1989;41(1-2):143–162. doi: 10.1016/0163-7258(89)90104-6. [DOI] [PubMed] [Google Scholar]
  15. Conti A., Monopoli A., Gamba M., Borea P. A., Ongini E. Effects of selective A1 and A2 adenosine receptor agonists on cardiovascular tissues. Naunyn Schmiedebergs Arch Pharmacol. 1993 Jul;348(1):108–112. doi: 10.1007/BF00168545. [DOI] [PubMed] [Google Scholar]
  16. De Mey J. G., Vanhoutte P. M. Role of the intima in cholinergic and purinergic relaxation of isolated canine femoral arteries. J Physiol. 1981 Jul;316:347–355. doi: 10.1113/jphysiol.1981.sp013792. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Drury A. N., Szent-Györgyi A. The physiological activity of adenine compounds with especial reference to their action upon the mammalian heart. J Physiol. 1929 Nov 25;68(3):213–237. doi: 10.1113/jphysiol.1929.sp002608. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Dunn P. M., Blakeley A. G. Suramin: a reversible P2-purinoceptor antagonist in the mouse vas deferens. Br J Pharmacol. 1988 Feb;93(2):243–245. doi: 10.1111/j.1476-5381.1988.tb11427.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Evans D. H. Evidence for the presence of A1 and A2 adenosine receptors in the ventral aorta of the dogfish shark, Squalus acanthias. J Comp Physiol B. 1992;162(2):179–183. doi: 10.1007/BF00398345. [DOI] [PubMed] [Google Scholar]
  20. Fredholm B. B., Abbracchio M. P., Burnstock G., Daly J. W., Harden T. K., Jacobson K. A., Leff P., Williams M. Nomenclature and classification of purinoceptors. Pharmacol Rev. 1994 Jun;46(2):143–156. [PMC free article] [PubMed] [Google Scholar]
  21. Fuglsang A., Therkildsen P., Crone C. Presynaptic modulation of sympathetic nerve transmission--an element in vasomotor control. Int J Microcirc Clin Exp. 1989 Feb;8(1):71–84. [PubMed] [Google Scholar]
  22. Gaddum J. H., Holtz P. The localization of the action of drugs on the pulmonary vessels of dogs and cats. J Physiol. 1933 Jan 16;77(2):139–158. doi: 10.1113/jphysiol.1933.sp002958. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Gallo-Rodriguez C., Ji X. D., Melman N., Siegman B. D., Sanders L. H., Orlina J., Fischer B., Pu Q., Olah M. E., van Galen P. J. Structure-activity relationships of N6-benzyladenosine-5'-uronamides as A3-selective adenosine agonists. J Med Chem. 1994 Mar 4;37(5):636–646. doi: 10.1021/jm00031a014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Gordon J. L. Extracellular ATP: effects, sources and fate. Biochem J. 1986 Jan 15;233(2):309–319. doi: 10.1042/bj2330309. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Hourani S. M., Chown J. A. The effects of some possible inhibitors of ectonucleotidases on the breakdown and pharmacological effects of ATP in the guinea-pig urinary bladder. Gen Pharmacol. 1989;20(4):413–416. doi: 10.1016/0306-3623(89)90188-2. [DOI] [PubMed] [Google Scholar]
  26. Houston D. A., Burnstock G., Vanhoutte P. M. Different P2-purinergic receptor subtypes of endothelium and smooth muscle in canine blood vessels. J Pharmacol Exp Ther. 1987 May;241(2):501–506. [PubMed] [Google Scholar]
  27. Hoyle C. H., Burnstock G. Evidence that ATP is a neurotransmitter in the frog heart. Eur J Pharmacol. 1986 May 27;124(3):285–289. doi: 10.1016/0014-2999(86)90229-3. [DOI] [PubMed] [Google Scholar]
  28. Hoyle C. H., Knight G. E., Burnstock G. Suramin antagonizes responses to P2-purinoceptor agonists and purinergic nerve stimulation in the guinea-pig urinary bladder and taenia coli. Br J Pharmacol. 1990 Mar;99(3):617–621. doi: 10.1111/j.1476-5381.1990.tb12979.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Hutchison A. J., Webb R. L., Oei H. H., Ghai G. R., Zimmerman M. B., Williams M. CGS 21680C, an A2 selective adenosine receptor agonist with preferential hypotensive activity. J Pharmacol Exp Ther. 1989 Oct;251(1):47–55. [PubMed] [Google Scholar]
  30. Jacobson K. A., Nikodijević O., Shi D., Gallo-Rodriguez C., Olah M. E., Stiles G. L., Daly J. W. A role for central A3-adenosine receptors. Mediation of behavioral depressant effects. FEBS Lett. 1993 Dec 20;336(1):57–60. doi: 10.1016/0014-5793(93)81608-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Lambrecht G., Friebe T., Grimm U., Windscheif U., Bungardt E., Hildebrandt C., Bäumert H. G., Spatz-Kümbel G., Mutschler E. PPADS, a novel functionally selective antagonist of P2 purinoceptor-mediated responses. Eur J Pharmacol. 1992 Jul 7;217(2-3):217–219. doi: 10.1016/0014-2999(92)90877-7. [DOI] [PubMed] [Google Scholar]
  32. Lazou A., Beis I. Effects of adenosine perfusion on the metabolism and contractile activity of Rana ridibunda heart. Comp Biochem Physiol C. 1987;86(2):415–419. doi: 10.1016/0742-8413(87)90106-x. [DOI] [PubMed] [Google Scholar]
  33. Lohse M. J., Klotz K. N., Schwabe U., Cristalli G., Vittori S., Grifantini M. 2-Chloro-N6-cyclopentyladenosine: a highly selective agonist at A1 adenosine receptors. Naunyn Schmiedebergs Arch Pharmacol. 1988 Jun;337(6):687–689. doi: 10.1007/BF00175797. [DOI] [PubMed] [Google Scholar]
  34. Londos C., Cooper D. M., Wolff J. Subclasses of external adenosine receptors. Proc Natl Acad Sci U S A. 1980 May;77(5):2551–2554. doi: 10.1073/pnas.77.5.2551. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Londos C., Wolff J. Two distinct adenosine-sensitive sites on adenylate cyclase. Proc Natl Acad Sci U S A. 1977 Dec;74(12):5482–5486. doi: 10.1073/pnas.74.12.5482. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Mathieson J. J., Burnstock G. Purine-mediated relaxation and constriction of isolated rabbit mesenteric artery are not endothelium-dependent. Eur J Pharmacol. 1985 Dec 3;118(3):221–229. doi: 10.1016/0014-2999(85)90132-3. [DOI] [PubMed] [Google Scholar]
  37. Meghji P., Burnstock G. An unusual excitatory action of adenosine on the ventricular muscle of the South African clawed toad (Xenopus laevis). Eur J Pharmacol. 1983 May 6;89(3-4):251–258. doi: 10.1016/0014-2999(83)90501-0. [DOI] [PubMed] [Google Scholar]
  38. Meghji P., Burnstock G. The effect of adenyl compounds on the heart of the dogfish, Scyliorhinus canicula. Comp Biochem Physiol C. 1984;77(2):295–300. doi: 10.1016/0742-8413(84)90016-1. [DOI] [PubMed] [Google Scholar]
  39. Meyerhof W., Müller-Brechlin R., Richter D. Molecular cloning of a novel putative G-protein coupled receptor expressed during rat spermiogenesis. FEBS Lett. 1991 Jun 24;284(2):155–160. doi: 10.1016/0014-5793(91)80674-r. [DOI] [PubMed] [Google Scholar]
  40. Moncada S., Vane J. R. Pharmacology and endogenous roles of prostaglandin endoperoxides, thromboxane A2, and prostacyclin. Pharmacol Rev. 1978 Sep;30(3):293–331. [PubMed] [Google Scholar]
  41. Nagano O., Földes F. F., Nakatsuka H., Reich D., Ohta Y., Sperlagh B., Vizi E. S. Presynaptic A1-purinoceptor-mediated inhibitory effects of adenosine and its stable analogues on the mouse hemidiaphragm preparation. Naunyn Schmiedebergs Arch Pharmacol. 1992 Aug;346(2):197–202. doi: 10.1007/BF00165301. [DOI] [PubMed] [Google Scholar]
  42. O'Connor S. E. Recent developments in the classification and functional significance of receptors for ATP and UTP, evidence for nucleotide receptors. Life Sci. 1992;50(22):1657–1664. doi: 10.1016/0024-3205(92)90420-t. [DOI] [PubMed] [Google Scholar]
  43. Ojewole J. A. Analysis of the responses of rainbow lizard (Agama agama Linn.). Isolated portal vein to electrical stimulation and to drugs. Methods Find Exp Clin Pharmacol. 1983 Dec;5(10):673–684. [PubMed] [Google Scholar]
  44. Olsson R. A., Pearson J. D. Cardiovascular purinoceptors. Physiol Rev. 1990 Jul;70(3):761–845. doi: 10.1152/physrev.1990.70.3.761. [DOI] [PubMed] [Google Scholar]
  45. Pearson J. D., Gordon J. L. P2 purinoceptors in the blood vessel wall. Biochem Pharmacol. 1989 Dec 1;38(23):4157–4163. doi: 10.1016/0006-2952(89)90509-1. [DOI] [PubMed] [Google Scholar]
  46. Ralevic V., Burnstock G. Roles of P2-purinoceptors in the cardiovascular system. Circulation. 1991 Jul;84(1):1–14. doi: 10.1161/01.cir.84.1.1. [DOI] [PubMed] [Google Scholar]
  47. Rees D. D., Palmer R. M., Hodson H. F., Moncada S. A specific inhibitor of nitric oxide formation from L-arginine attenuates endothelium-dependent relaxation. Br J Pharmacol. 1989 Feb;96(2):418–424. doi: 10.1111/j.1476-5381.1989.tb11833.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Rees D. D., Palmer R. M., Schulz R., Hodson H. F., Moncada S. Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. Br J Pharmacol. 1990 Nov;101(3):746–752. doi: 10.1111/j.1476-5381.1990.tb14151.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Saiag B., Milon D., Shacoori V., Allain H., Rault B., Van Den Driessche J. Newly evidenced pyrimidinoceptors and the P2x purinoceptors are present on the vascular smooth muscle and respectively mediate the UTP- and ATP-induced contractions of the dog maxillary internal vein. Res Commun Chem Pathol Pharmacol. 1992 Apr;76(1):89–94. [PubMed] [Google Scholar]
  50. Saïag B., Milon D., Allaín H., Rault B., Van den Driessche J. Constriction of the smooth muscle of rat tail and femoral arteries and dog saphenous vein is induced by uridine triphosphate via 'pyrimidinoceptors', and by adenosine triphosphate via P2x purinoceptors. Blood Vessels. 1990;27(6):352–364. doi: 10.1159/000158829. [DOI] [PubMed] [Google Scholar]
  51. Small S. A., MacDonald C., Farrell A. P. Vascular reactivity of the coronary artery in rainbow trout (Oncorhynchus mykiss). Am J Physiol. 1990 Jun;258(6 Pt 2):R1402–R1410. doi: 10.1152/ajpregu.1990.258.6.R1402. [DOI] [PubMed] [Google Scholar]
  52. Stone T. W. Receptors for adenosine and adenine nucleotides. Gen Pharmacol. 1991;22(1):25–31. doi: 10.1016/0306-3623(91)90305-p. [DOI] [PubMed] [Google Scholar]
  53. Su C. Extracellular functions of nucleotides in heart and blood vessels. Annu Rev Physiol. 1985;47:665–676. doi: 10.1146/annurev.ph.47.030185.003313. [DOI] [PubMed] [Google Scholar]
  54. Vane J. R. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat New Biol. 1971 Jun 23;231(25):232–235. doi: 10.1038/newbio231232a0. [DOI] [PubMed] [Google Scholar]
  55. Verhaeghe R. H., Vanhoutte P. M., Shepherd J. T. Inhibition of sympathetic neurotransmission in canine blood vessels by adenosine and adenine nucleotides. Circ Res. 1977 Feb;40(2):208–215. doi: 10.1161/01.res.40.2.208. [DOI] [PubMed] [Google Scholar]
  56. Vials A. J., Burnstock G. Effects of pyrimidines on the guinea-pig coronary vasculature. Br J Pharmacol. 1993 Nov;110(3):1091–1097. doi: 10.1111/j.1476-5381.1993.tb13926.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Vials A., Burnstock G. A2-purinoceptor-mediated relaxation in the guinea-pig coronary vasculature: a role for nitric oxide. Br J Pharmacol. 1993 Jun;109(2):424–429. doi: 10.1111/j.1476-5381.1993.tb13586.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Zhou Q. Y., Li C., Olah M. E., Johnson R. A., Stiles G. L., Civelli O. Molecular cloning and characterization of an adenosine receptor: the A3 adenosine receptor. Proc Natl Acad Sci U S A. 1992 Aug 15;89(16):7432–7436. doi: 10.1073/pnas.89.16.7432. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Ziganshin A. U., Hoyle C. H., Bo X., Lambrecht G., Mutschler E., Bäumert H. G., Burnstock G. PPADS selectively antagonizes P2X-purinoceptor-mediated responses in the rabbit urinary bladder. Br J Pharmacol. 1993 Dec;110(4):1491–1495. doi: 10.1111/j.1476-5381.1993.tb13990.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Ziganshin A. U., Hoyle C. H., Lambrecht G., Mutschler E., Bümert H. G., Burnstock G. Selective antagonism by PPADS at P2X-purinoceptors in rabbit isolated blood vessels. Br J Pharmacol. 1994 Mar;111(3):923–929. doi: 10.1111/j.1476-5381.1994.tb14827.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. Ziganshin A. U., Ziganshina L. E., King B. E., Burnstock G. Characteristics of ecto-ATPase of Xenopus oocytes and the inhibitory actions of suramin on ATP breakdown. Pflugers Arch. 1995 Jan;429(3):412–418. doi: 10.1007/BF00374157. [DOI] [PubMed] [Google Scholar]
  62. van Calker D., Müller M., Hamprecht B. Adenosine regulates via two different types of receptors, the accumulation of cyclic AMP in cultured brain cells. J Neurochem. 1979 Nov;33(5):999–1005. doi: 10.1111/j.1471-4159.1979.tb05236.x. [DOI] [PubMed] [Google Scholar]
  63. von Kügelgen I., Häussinger D., Starke K. Evidence for a vasoconstriction-mediating receptor for UTP, distinct from the P2 purinoceptor, in rabbit ear artery. Naunyn Schmiedebergs Arch Pharmacol. 1987 Nov;336(5):556–560. doi: 10.1007/BF00169313. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES